Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs GSK✓SelectedUSD · GSKMRNA vs GSK performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+212.6%
GSK return
-3.4%
Excess return
+216.0%
Maximum drawdown
-26.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.8%-1.3%-3.5%+1.2%
7D-20.9%-3.1%-17.7%-9.1%
30D-13.3%-0.9%-12.4%-21.3%
3M+212.6%-4.2%+216.7%+284.6%
All+212.6%-3.4%+216.0%+284.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3mo analysis · Full analysis span regression · Available span rolling